Resham Bhattacharya to Drug Delivery Systems
                            
                            
                                This is a "connection" page, showing publications Resham Bhattacharya has written about Drug Delivery Systems.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.542
         
        
        
     
 
    
        
        - 
            Hybrid Nanosystems for Biomedical Applications. ACS Nano. 2021 02 23; 15(2):2099-2142.
            
            
                Score: 0.149
             
- 
            Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro. Int J Nanomedicine. 2020; 15:991-1003.
            
            
                Score: 0.139
             
- 
            Inorganic nanoparticles in cancer therapy. Pharm Res. 2011 Feb; 28(2):237-59.
            
            
                Score: 0.074
             
- 
            Biological properties of "naked" metal nanoparticles. Adv Drug Deliv Rev. 2008 Aug 17; 60(11):1289-1306.
            
            
                Score: 0.061
             
- 
            Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res. 2008 Mar 15; 68(6):1970-8.
            
            
                Score: 0.061
             
- 
            Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6700-5.
            
            
                Score: 0.022
             
- 
            Cancer nanotechnology: emerging role of gold nanoconjugates. Anticancer Agents Med Chem. 2011 Dec; 11(10):965-73.
            
            
                Score: 0.020
             
- 
            Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev. 2010 Mar 08; 62(3):346-61.
            
            
                Score: 0.017